共 50 条
- [31] First-line anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy in Japanese mucosal melanoma: A retrospective, multicenter study (JMAC study)ANNALS OF ONCOLOGY, 2021, 32 : S876 - S876Nakamura, Y.论文数: 0 引用数: 0 h-index: 0机构: Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, JapanNamikawa, K.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp Tsukiji Campus, Dept Dermatol Oncol, Tokyo, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, JapanYoshikawa, S.论文数: 0 引用数: 0 h-index: 0机构: Shizuoka Canc Ctr, Dept Dermatol, Shizuoka, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, JapanKiniwa, Y.论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Dept Dermatol, Matsumoto, Nagano, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, JapanMaekawa, T.论文数: 0 引用数: 0 h-index: 0机构: Jichi Med Univ Hosp, Dept Dermatol, Shimotsuke, Tochigi, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, JapanYamasaki, O.论文数: 0 引用数: 0 h-index: 0机构: Okayama Univ, Dept Dermatol, Okayama, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, JapanIsei, T.论文数: 0 引用数: 0 h-index: 0机构: Osaka Int Canc Inst, Dept Dermatol Oncol, Osaka, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, JapanMatsushita, S.论文数: 0 引用数: 0 h-index: 0机构: Natl Hosp Org, Kagoshima Med Ctr, Dept Dermatooncol Dermatol, Kagoshima, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, Japan论文数: 引用数: h-index:机构:Nakai, Y.论文数: 0 引用数: 0 h-index: 0机构: Mie Univ, Dept Dermatol, Tsu, Mie, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, JapanFukushima, S.论文数: 0 引用数: 0 h-index: 0机构: Kumamoto Univ, Dept Dermatol, Kumamoto, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, Japan论文数: 引用数: h-index:机构:Takenouchi, T.论文数: 0 引用数: 0 h-index: 0机构: Niigata Canc Ctr Hosp, Dept Dermatol, Niigata, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, JapanTanaka, R.论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Dept Dermatol, Kurashiki, Okayama, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, JapanKato, H.论文数: 0 引用数: 0 h-index: 0机构: Nagoya City Univ, Dept Dermatol, Nagoya, Aichi, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, JapanOtsuka, A.论文数: 0 引用数: 0 h-index: 0机构: Kyoto Univ Hosp, Dept Dermatol, Kyoto, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, JapanMatsuya, T.论文数: 0 引用数: 0 h-index: 0机构: Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, JapanBaba, N.论文数: 0 引用数: 0 h-index: 0机构: Univ Fukui, Dept Dermatol, Fukui, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, JapanNagase, K.论文数: 0 引用数: 0 h-index: 0机构: Saga Univ, Dept Dermatol, Saga, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, JapanInozume, T.论文数: 0 引用数: 0 h-index: 0机构: Chiba Univ, Dept Dermatol, Chiba, Japan Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, Japan
- [32] Adjuvant anti-PD-1 monotherapy benefit varies across different ethnicities and melanoma subtypesANNALS OF ONCOLOGY, 2022, 33 (07) : S914 - S915Bai, X.论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaGerstberger, S.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaPark, B.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Med, Med Ctr, Nashville, TN USA Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaJung, S.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Med, Med Ctr, Nashville, TN USA Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaJohnson, R.论文数: 0 引用数: 0 h-index: 0机构: Melanoma Inst Australia, Med, Wollstonecraft, NSW, Australia Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaYamazaki, N.论文数: 0 引用数: 0 h-index: 0机构: NCCH Natl Canc Ctr Hosp, Dept Dermatol Oncol, Chuo ku, Tokyo, Japan Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaOgata, D.论文数: 0 引用数: 0 h-index: 0机构: NCCH Natl Canc Ctr Hosp, Dept Dermatol Oncol, Chuo ku, Tokyo, Japan Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaUmeda, Y.论文数: 0 引用数: 0 h-index: 0机构: Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Saitama, Japan Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaLi, C.论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Dept Melanoma & Sarcoma, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaSi, L.论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Dept Melanoma & Sarcoma, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaFlaherty, K.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaNakamura, Y.论文数: 0 引用数: 0 h-index: 0机构: Saitama Med Univ, Dept Skin Oncol Dermatol, Int Med Ctr, Hidaka, Japan Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaNamikawa, K.论文数: 0 引用数: 0 h-index: 0机构: NCCH Natl Canc Ctr Hosp, Dept Dermatol Oncol, Chuo ku, Tokyo, Japan Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaLong, G. V.论文数: 0 引用数: 0 h-index: 0机构: Melanoma Inst Australia, Med, Wollstonecraft, NSW, Australia Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaMenzies, A. M.论文数: 0 引用数: 0 h-index: 0机构: Melanoma Inst Australia, Med Oncol Dept, Suite 5-6, Wollstonecraft, NSW, Australia Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaJohnson, D. B.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Med, Med Ctr, Nashville, TN USA Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaSullivan, R. J.论文数: 0 引用数: 0 h-index: 0机构: Mass Gen Canc Ctr, Med, Boston, MA USA Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaBoland, G.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Surg, Surg Oncol Div, Boston, MA USA Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R ChinaGuo, J.论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Dept Melanoma & Sarcoma, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Massachusetts Gen Hosp, Dept Melanoma & Sarcoma, Beijing, Peoples R China
- [33] Combination between a long-acting engineered cytokine (NKTR-214) and checkpoint inhibitors anti-CTLA4 or anti-PD1 in inurine tumor modelsJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)Kantak, Seema S.论文数: 0 引用数: 0 h-index: 0机构: Nektar Therapeut, San Francisco, CA USA Nektar Therapeut, San Francisco, CA USALee, Steve论文数: 0 引用数: 0 h-index: 0机构: Nektar Therapeut, San Francisco, CA USA Nektar Therapeut, San Francisco, CA USAAddepalli, Murali论文数: 0 引用数: 0 h-index: 0机构: Nektar Therapeut, San Francisco, CA USA Nektar Therapeut, San Francisco, CA USAHoch, Ute论文数: 0 引用数: 0 h-index: 0机构: Nektar Therapeut, San Francisco, CA USA Nektar Therapeut, San Francisco, CA USAPenax, Rhoneil论文数: 0 引用数: 0 h-index: 0机构: Nektar Therapeut, San Francisco, CA USA Nektar Therapeut, San Francisco, CA USAPena, Rhoneil论文数: 0 引用数: 0 h-index: 0机构: Nektar Therapeut, San Francisco, CA USA Nektar Therapeut, San Francisco, CA USAKirksey, Yolanda论文数: 0 引用数: 0 h-index: 0机构: Nektar Therapeut, San Francisco, CA USA Nektar Therapeut, San Francisco, CA USACharych, Deborah H.论文数: 0 引用数: 0 h-index: 0机构: Nektar Therapeut, San Francisco, CA USA Nektar Therapeut, San Francisco, CA USADoberstein, Stephen K.论文数: 0 引用数: 0 h-index: 0机构: Nektar Therapeut, San Francisco, CA USA Nektar Therapeut, San Francisco, CA USA
- [34] Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefitCANCER, 2022, 128 (05) : 975 - 983Patel, Anisha B.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USA Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USAFarooq, Sahira论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USAWelborn, Macartney论文数: 0 引用数: 0 h-index: 0机构: Univ Florida, Dept Dermatol, Gainesville, FL USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USAAmaria, Rodabe N.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USAChon, Susan Y.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USADiab, Adi论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USAOliva, Isabella C. Glitza论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USAHuen, Auris O.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USALi, Shirley Q.论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USANelson, Kelly C.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USA Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USAPacha, Omar论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USAPatel, Sapna P.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USARapini, Ronald P.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USA Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USATawbi, Hussein A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USAWong, Michael K.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USAMcQuade, Jennifer论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USADavies, Michael A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USAHaydu, Lauren E.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Dermatol, 1515 Holcombe Blvd,Unit 1452, Houston, TX 77030 USA
- [35] Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapyCancer Immunology, Immunotherapy, 2022, 71 : 1681 - 1691Qiaoyun Tan论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Liyuan Dai论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Yanrong Wang论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Shuxia Liu论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Te Liang论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Rongrong Luo论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Shasha Wang论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Ning Lou论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Haizhu Chen论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Yu Zhou论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Qiaofeng Zhong论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Jianliang Yang论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Puyuan Xing论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Xingsheng Hu论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Yutao Liu论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Shengyu Zhou论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Jiarui Yao论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Di Wu论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Zhishang Zhang论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Le Tang论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Xiaobo Yu论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Xiaohong Han论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,Yuankai Shi论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology,
- [36] Hepatic and digestive adverse events of immune checkpoint inhibitors (anti-CTLA-4 and, anti-PD-1/PD-L1): A clinico-pathological reviewANNALES DE PATHOLOGIE, 2018, 38 (06) : 338 - 351Papouin, Barbara论文数: 0 引用数: 0 h-index: 0机构: Hop Bicetre, AP HP, Serv Anat & Cytol Pathol, 78,Rue Gen Leclerc, F-94270 Le Kremlin Bicetre, France Hop Bicetre, AP HP, Serv Anat & Cytol Pathol, 78,Rue Gen Leclerc, F-94270 Le Kremlin Bicetre, FranceMussini, Charlotte论文数: 0 引用数: 0 h-index: 0机构: Hop Bicetre, AP HP, Serv Anat & Cytol Pathol, 78,Rue Gen Leclerc, F-94270 Le Kremlin Bicetre, France Hop Bicetre, AP HP, Serv Anat & Cytol Pathol, 78,Rue Gen Leclerc, F-94270 Le Kremlin Bicetre, FranceDe Martin, Eleonora论文数: 0 引用数: 0 h-index: 0机构: Hop Paul Brousse, AP HP, Ctr Hepatobiliaire, 12,Ave Paul Valliant Couturier, F-94800 Villejuif, France Hop Bicetre, AP HP, Serv Anat & Cytol Pathol, 78,Rue Gen Leclerc, F-94270 Le Kremlin Bicetre, FranceGuettier, Catherine论文数: 0 引用数: 0 h-index: 0机构: Hop Bicetre, AP HP, Serv Anat & Cytol Pathol, 78,Rue Gen Leclerc, F-94270 Le Kremlin Bicetre, France Univ Paris Saclay, Fac Med Paris Sud, F-94276 Le Kremlin Bicetre, France Hop Paul Brousse, Inserm 1193, F-94800 Villejuif, France Hop Bicetre, AP HP, Serv Anat & Cytol Pathol, 78,Rue Gen Leclerc, F-94270 Le Kremlin Bicetre, France
- [37] RORγ agonist enhances antitumor effects of immune checkpoint anti-PD1CANCER RESEARCH, 2018, 78 (13)Gaur, Pankaj论文数: 0 引用数: 0 h-index: 0机构: Augusta Univ, Georgia Canc Ctr, Augusta, GA USA Augusta Univ, Georgia Canc Ctr, Augusta, GA USAVerma, Vivek论文数: 0 引用数: 0 h-index: 0机构: Augusta Univ, Georgia Canc Ctr, Augusta, GA USA Augusta Univ, Georgia Canc Ctr, Augusta, GA USANandre, Rahul论文数: 0 引用数: 0 h-index: 0机构: Augusta Univ, Georgia Canc Ctr, Augusta, GA USA Augusta Univ, Georgia Canc Ctr, Augusta, GA USAVir, Pooja论文数: 0 引用数: 0 h-index: 0机构: Augusta Univ, Georgia Canc Ctr, Augusta, GA USA Augusta Univ, Georgia Canc Ctr, Augusta, GA USAWang, Hua论文数: 0 引用数: 0 h-index: 0机构: Augusta Univ, Georgia Canc Ctr, Augusta, GA USA Augusta Univ, Georgia Canc Ctr, Augusta, GA USAKang, Baolin论文数: 0 引用数: 0 h-index: 0机构: Augusta Univ, Georgia Canc Ctr, Augusta, GA USA Augusta Univ, Georgia Canc Ctr, Augusta, GA USACarter, Laura论文数: 0 引用数: 0 h-index: 0机构: Lycera Corp, Ann Arbor, MI USA Augusta Univ, Georgia Canc Ctr, Augusta, GA USAHu, Xiao论文数: 0 引用数: 0 h-index: 0机构: Lycera Corp, Ann Arbor, MI USA Augusta Univ, Georgia Canc Ctr, Augusta, GA USALiu, Xikui论文数: 0 引用数: 0 h-index: 0机构: Lycera Corp, Ann Arbor, MI USA Augusta Univ, Georgia Canc Ctr, Augusta, GA USAGupta, Seema论文数: 0 引用数: 0 h-index: 0机构: Augusta Univ, Georgia Canc Ctr, Augusta, GA USA Augusta Univ, Georgia Canc Ctr, Augusta, GA USAKhleif, Samir论文数: 0 引用数: 0 h-index: 0机构: Augusta Univ, Georgia Canc Ctr, Augusta, GA USA Augusta Univ, Georgia Canc Ctr, Augusta, GA USA
- [38] Effect of radiofrequency ablation (RFA) combined with anti-CTLA-4 and anti-PD1 in a preclinical melanoma model.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)Franco-Mahecha, Olga L.论文数: 0 引用数: 0 h-index: 0机构: NIH, Ctr Intervent Oncol, Bldg 10, Bethesda, MD 20892 USA NIH, Ctr Intervent Oncol, Bldg 10, Bethesda, MD 20892 USAChristou, Anna论文数: 0 引用数: 0 h-index: 0机构: NIH, Ctr Intervent Oncol, Bldg 10, Bethesda, MD 20892 USA NIH, Ctr Intervent Oncol, Bldg 10, Bethesda, MD 20892 USAMauda-Havakuk, Michal论文数: 0 引用数: 0 h-index: 0机构: NIH, Ctr Intervent Oncol, Bldg 10, Bethesda, MD 20892 USA NIH, Ctr Intervent Oncol, Bldg 10, Bethesda, MD 20892 USAKatti, Prateek论文数: 0 引用数: 0 h-index: 0机构: NIH, Ctr Intervent Oncol, Bldg 10, Bethesda, MD 20892 USA NIH, Ctr Intervent Oncol, Bldg 10, Bethesda, MD 20892 USAPritchard, William F.论文数: 0 引用数: 0 h-index: 0机构: NIH, Ctr Intervent Oncol, Bldg 10, Bethesda, MD 20892 USA NIH, Ctr Intervent Oncol, Bldg 10, Bethesda, MD 20892 USAKaranian, John W.论文数: 0 引用数: 0 h-index: 0机构: NIH, Ctr Intervent Oncol, Bldg 10, Bethesda, MD 20892 USA NIH, Ctr Intervent Oncol, Bldg 10, Bethesda, MD 20892 USAWood, Bradford J.论文数: 0 引用数: 0 h-index: 0机构: NIH, Ctr Intervent Oncol, Bldg 10, Bethesda, MD 20892 USA NIH, Ctr Intervent Oncol, Bldg 10, Bethesda, MD 20892 USA
- [39] Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapyCANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (07) : 1681 - 1691Tan, Qiaoyun论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaDai, Liyuan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaWang, Yanrong论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaLiu, Shuxia论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaLiang, Te论文数: 0 引用数: 0 h-index: 0机构: Beijing Inst Life, Beijing Proteome Res Ctr, Natl Ctr Prot Sci Beijing PHOENIX Ctr, State Key Lab Prote, Beijing 102206, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaLuo, Rongrong论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaWang, Shasha论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaLou, Ning论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaChen, Haizhu论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaZhou, Yu论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaZhong, Qiaofeng论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaYang, Jianliang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaXing, Puyuan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaHu, Xingsheng论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaLiu, Yutao论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaZhou, Shengyu论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaYao, Jiarui论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaWu, Di论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaZhang, Zhishang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaTang, Le论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaYu, Xiaobo论文数: 0 引用数: 0 h-index: 0机构: Beijing Inst Life, Beijing Proteome Res Ctr, Natl Ctr Prot Sci Beijing PHOENIX Ctr, State Key Lab Prote, Beijing 102206, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaHan, Xiaohong论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, NMPA Key Lab Clin Res & Evaluat Drug, Peking Union Med Coll Hosp,Clin Pharmacol Res Ctr, State Key Lab Complex Severe & Rare Dis,Beijing K, Beijing 100032, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R ChinaShi, Yuankai论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China
- [40] PHY906(YIV-906), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Immune checkpoint blockade therapy: anti-PDL1, anti-PD1, anti-PD1/CTLA4 against melanomaCANCER RESEARCH, 2017, 77Lam, Wing论文数: 0 引用数: 0 h-index: 0Jiang, Zaoli论文数: 0 引用数: 0 h-index: 0Han, Xue论文数: 0 引用数: 0 h-index: 0Liu, Shwu-Huey论文数: 0 引用数: 0 h-index: 0Chen, Lieping论文数: 0 引用数: 0 h-index: 0Cheng, YungChi论文数: 0 引用数: 0 h-index: 0